SCHEMBL6295212

SCHEMBL6295212

[CH2]c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 3/20 0.61
▸ HRH3 Q9Y5N1 1/20 0.51
▸ KMT2A Q03164 9/20 0.49
▸ MEN1 O00255 8/20 0.49
▸ MAPT P10636 6/20 0.49
▸ LMNA P02545 6/20 0.49
▸ CNR1 P21554 2/20 0.48
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ POLB P06746 2/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ IDH2 P48735 1/20 0.47
▸ EPHX1 P07099 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24272430 0.84 MAOA (0.61) NPSR1HRH3KMT2AMEN1MAPT
SCHEMBL3419678 0.83 NPSR1 (0.59) NPSR1HRH3KMT2AMEN1MAPT
SCHEMBL5639249 0.80 SMN1; SMN2 (0.68) NPSR1HRH3KMT2AMEN1MAPT
SCHEMBL5640003 0.79 KMT2A (0.69) NPSR1KMT2AMEN1MAPTLMNA
SCHEMBL6301846 0.79 KMT2A (0.63) NPSR1KMT2AMEN1MAPTLMNA
SCHEMBL5149711 0.78 MEN1 (0.60) NPSR1HRH3KMT2AMEN1RAB9A
SCHEMBL95460 0.77 SMN1; SMN2 (0.74) NPSR1KMT2AMEN1MAPTLMNA
SCHEMBL95630 0.77 TYK2 (0.65) NPSR1KMT2AMAPTRAB9AGAA
SCHEMBL10439806 0.74 ADRA2A (0.40) NPSR1KMT2AMEN1LMNACYP1A2
SCHEMBL1492854 0.73 NPSR1 (0.61) NPSR1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903128-B2 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases PFIZER INC (US) 2005-06-07 — — US disclosed
US-6667331-B2 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )-3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid PFIZER INC 2003-12-23 — — US disclosed
US-6355662-B1 PEPTIDE AND NONPEPTIDES AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS PFIZER INC 2002-03-12 — — US disclosed
US-6306887-B1 AROMATIC UREAS, CARBAMATES AND TRIAMINONITRILES AND HETEROCYCLIC COMPOUNDS PFIZER INC 2001-10-23 — — US disclosed
Send feedback